Kidney International (1981) 19, 710–715; doi:10.1038/ki.1981.71
Urine and serum lactic dehydrogenase, lactic dehydrogenase isoenzymes, and alkaline phosphatase in the nephrotic syndrome
Charles B Murdock1, Patricia J Baker1, Elizabeth DeLong1, Charles R Roe1 and Stephen G Osofsky1
1Departments of Pediatrics and Community and Family Medicine, Duke University Medical Center, Durham, North Carolina
Correspondence: Dr S G Osofsky, Department of Pediatrics, Division of Pediatric Nephrology, P.O. Box 3959, Duke University Medical Center, Durham, North Carolina 27710, USA.
Received 31 July 1980; Revised 2 September 1980.
Top of pageAbstract
Urine and serum lactic dehydrogenase, lactic dehydrogenase isoenzymes, and alkaline phosphatase in the nephrotic syndrome. Urinary and serum lactic dehydrogenase (LDH), its isoenzymes, and alkaline phosphatase (AP) activities were determined for children with known nephrotic syndrome (NS) (N = 31) and for normal controls (N = 35 for urine, N = 56 for serum). Patients with NS were grouped as being in relapse, in remission without prednisone, in remission for greater than 21 days with prednisone therapy, or in remission for less than 21 days with prednisone therapy. The relapse group had significant elevations of urinary LDH and AP when compared with each of the other groups. The highest urinary LDH values were seen in the relapse group, and the lowest in normal controls. The groups in remission had intermediate values of urinary LDH, which decreased as the length of time in remission increased. Although urinary AP activities were elevated in patients in relapse, they were subnormal in patients in remission greater than 21 days with prednisone therapy, suggesting membrane stabilization with resultant reduction in enzyme release into the urinary tract. The urinary and serum LDH isoenzyme patterns in the relapse group did not resemble each other, indicating the increased urinary activity was not due solely to renal clearance of serum enzymes. Serum LDH was elevated in the relapse group (P < 0.01), but it was not statistically different in the remission group when compared with controls. This study demonstrates increased urinary LDH, AP, and serum LDH activities in patients with the relapsed NS. In relapsed patients, the different serum and urine LDH isoenzyme patterns suggest that the urinary activity may be a result of diseased renal tissue and not a reflection of increased glomerular filtration. Monitoring the urinary LDH activity may allow for detecting the continuing disease at a time when other clinical signs have normalized.
Déhydrogénase lactique du sérum de l'urine, isoenzymes de la LDH et phosphatases alcalines dans le syndrome néphrotique. La LDH du sérum et de l'urine, les isoenzymes de la LDH et la phosphatase alcaline (AP) ont été déterminées chez 31 enfants atteints de syndrome néphrotique (NS) et chez des sujets contrôles (N = 35 pour l'urine, N = 56 pour le sérum). Les malades atteints de NS ont été groupés en récidives, rémissions sans prednisone, rémissions depuis plus de 21 jours recevant de la prednisone, rémissions de moins de 21 jours recevant de la prednisone. Le groupe des récidives avait des augmentations significatives de LDH et AP par comparaison avec chacun des autres groupes. Les valeurs les plus élevées de LDH urinaire ont été observées dans le groupe des récidives et les plus faibles chez les normaux. Les groupes en rémission avaient des valeurs intermédiaires de LDH urinaire, valeurs qui diminuent en même temps que la durée de rémission s'allonge. Les valeurs d'AP urinaire étaient élevées dans les récidives, les malades en rémission depuis plus de 21 jours recevant de la prednisone avaient des activités d'AP inférieures à la normale, ce qui suggère la stabilisation de la membrane avec comme résultat la libération de l'enzyme dans l'appareil urinaire. La répartition des isoenzymes était différente dans le sérum et l'urine du groupe en récidive, ce qui indique que l'augmentation d'activité urinaire n'était pas seulement due à l'augmentation de la clearance rénale des enzymes. La LDH sérique était élevée dans les récidives (P < 0,01) mais le groupe en rémission n'était pas significativement différent des contrôles. Cette étude démontre une augmentation de l'activité urinaire de LDH et AP et de l'activité de la LDH sérique chez les malades en rechute de NS. Chez ces malades, la distribution différente des isoenzymes dans le sérum et l'urine suggère que l'augmentation d'activité urinaire puisse avoir pour origine le tissu rénal altéré et ne reflète pas l'augmentation de la quantité filtrée. La surveillance de l'activité LDH dans l'urine peut permettre la détection de la persistance de la maladie à un moment où d'autres éléments sont normalisés.
Top of pageReferences
- Rosalki SB, Wilkinson JH: Urinary lactic dehydrogenase in renal disease. Lancet 2:327–328, 1959
- Crockson RA: Lactic dehydrogenase in renal disease. Lancet 1:140–143, 1961
- Riggins RS, Kiser WS: A study of lactic dehydrogenase in the urine and serum of patients with urinary tract disease. J Urol 90:594–603, 1963
- Riggins RS, Kiser WS: Lactic dehydrogenase isoenzymes in urine. Invest Urol 2:30–37, 1964
- Amador E, Dorfman LE, Wacker WEC: Urinary alkaline phosphatase and LDH activities in the differential diagnosis of renal disease. Ann Intern Med 62:30–40, 1965
- Guttler F, Clausen J: Urinary lactate dehydrogenase activity: Determination of the urinary LDH isoenzyme pattern as a supplement to the measurement of total urinary LDH activity. Enzyme 5:55–64, 1965
- Gault MH, Steiner G: Serum and urinary enzyme activity after renal infarction. Can Med Assoc J 93:1101–1105, 1965
- Goldberg WM, Chakrabarti S, Filipich R: Urinary lactic dehydrogenase, alkaline phosphatase and lysozyme studies in renal disease. Can Med Assoc J 94:1264–1268, 1966
- Gault MH and Gegie PHS: Clinical significance of urinary LDH, alkaline phosphatase and other enzymes. Can Med Assoc J 101:208–215, 1969
- Carvajal HF, Passey RB, Berger M, Travis LB, Lorentz WB: Urinary lactic dehydrogenase isoenzyme 5 in the differential diagnosis of kidney and bladder infections. Kidney Int 8:176–184, 1975
- Miyao M, Hasegawa Y, Matsuda H, Matsumara I, Imaoka M: Urinary alkaline phosphatase level in children. Tokushima J Exp Med 15:65–70, 1968
- Serban M: Urinary LDH activity and its isoenzyme pattern in renal pathology. Rev Roum Med Intern 10:43–47, 1973
- Gavosto JJ, Fay OH, Garcia CA, Arnolt RI: Study of the proteins, enzymes and isoenzymes in serum and urine and the serum lipids in the nephrotic syndrome. Arch Fund Roux Ocefa 5:73–79, 1971
- Nephrotic syndrome in children: Prediction of histopathology from clinical and laboratory characteristics at the time of diagnosis: A report of the International Study of Kidney Disease in Children. Kidney Int 13:159–165, 1978
- Amador E, Zimmerman TS, Wacker WEC: Urinary alkaline phosphatase activity: II. Analytic validation of the assay method. JAMA 185:953–957, 1963
- Amador E, Dorfman LE, Wacker WEC: Serum lactic dehydrogenase activity: an analytic assessment of current assays. Clin Chem 9:391–399, 1963 | ISI | ChemPort |
- Bowers GN Jr, McComb RB: A continuous spectrophotometry method for measuring the activity of serum alkaline phosphatase. Clin Chem 12:70–89, 1966
- Roe CR, Wagner GS, Young WG, Curtis SE, Cobb FR, Irvin RG: Relation of creatine kinase isoenzyme MB to postoperative electrocardiographic diagnosis in patients undergoing coronary artery bypass surgery. Clin Chem 25:93–98, 1979
- Vesell ES: Significance of heterogeneity of lactic dehydrogenase activity in human tissues. Ann NY Acad Sci 94:877–889, 1961 | PubMed | ChemPort |
- Werner M, Heilbron DC, Maruhn D, Atoba M: Patterns of urinary enzyme excretion in healthy subjects. Clin Chim Acta 29:437–449, 1970
- Papadopoulos NM: Clinical applications of lactate dehydrogenase isoenzymes. Ann Clin Lab Sci 7:506–510, 1977